172 related articles for article (PubMed ID: 23883558)
1. Clinical characteristics and neuroimaging findings in 12 cases of recurrent glioblastoma with communicating hydrocephalus.
Onuma K; Ishikawa E; Matsuda M; Hirata K; Osuka S; Yamamoto T; Masumoto T; Zaboronok A; Matsumura A
Neurol Med Chir (Tokyo); 2013; 53(7):474-81. PubMed ID: 23883558
[TBL] [Abstract][Full Text] [Related]
2. Communicating hydrocephalus following surgery and adjuvant radiochemotherapy for glioblastoma.
Montano N; D'Alessandris QG; Bianchi F; Lauretti L; Doglietto F; Fernandez E; Maira G; Pallini R
J Neurosurg; 2011 Dec; 115(6):1126-30. PubMed ID: 21905801
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma.
Tejada-Solís S; Aldave-Orzaiz G; Pay-Valverde E; Marigil-Sánchez M; Idoate-Gastearena MA; Díez-Valle R
Acta Neurochir (Wien); 2012 Nov; 154(11):1997-2002; discussion 2002. PubMed ID: 22930281
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
6. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.
Bag AK; Cezayirli PC; Davenport JJ; Gaddikeri S; Fathallah-Shaykh HM; Cantor A; Han XS; Nabors LB
J Neurooncol; 2014 Nov; 120(2):361-70. PubMed ID: 25098699
[TBL] [Abstract][Full Text] [Related]
8. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
10. Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.
Hong B; Wiese B; Bremer M; Heissler HE; Heidenreich F; Krauss JK; Nakamura M
Am J Clin Oncol; 2013 Jun; 36(3):261-8. PubMed ID: 22495452
[TBL] [Abstract][Full Text] [Related]
11. Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?
Gupta T; Nair V; Paul SN; Kannan S; Moiyadi A; Epari S; Jalali R
J Neurooncol; 2012 Aug; 109(1):195-203. PubMed ID: 22555992
[TBL] [Abstract][Full Text] [Related]
12. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
13. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
14. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.
Audureau E; Chivet A; Ursu R; Corns R; Metellus P; Noel G; Zouaoui S; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Petit A; Emery E; Lechapt-Zalcman E; Peltier J; Duntze J; Dezamis E; Voirin J; Menei P; Caire F; Dam Hieu P; Barat JL; Langlois O; Vignes JR; Fabbro-Peray P; Riondel A; Sorbets E; Zanello M; Roux A; Carpentier A; Bauchet L; Pallud J;
J Neurooncol; 2018 Feb; 136(3):565-576. PubMed ID: 29159777
[TBL] [Abstract][Full Text] [Related]
16. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
Pichlmeier U; Bink A; Schackert G; Stummer W;
Neuro Oncol; 2008 Dec; 10(6):1025-34. PubMed ID: 18667747
[TBL] [Abstract][Full Text] [Related]
17. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
Thomas JG; Rao G; Kew Y; Prabhu SS
Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
[TBL] [Abstract][Full Text] [Related]
18. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
Pope WB; Kim HJ; Huo J; Alger J; Brown MS; Gjertson D; Sai V; Young JR; Tekchandani L; Cloughesy T; Mischel PS; Lai A; Nghiemphu P; Rahmanuddin S; Goldin J
Radiology; 2009 Jul; 252(1):182-9. PubMed ID: 19561256
[TBL] [Abstract][Full Text] [Related]
19. Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
